SigmaPharm Looks To Relaunch Skelaxin Antitrust Battle
SigmaPharm Inc. on Wednesday sought a fresh start in its long-running antitrust fight with King Pharmaceuticals Inc. and Mutual Pharmaceutical Co. Inc., which it accuses of masterminding a conspiracy to suppress the...To view the full article, register now.
Already a subscriber? Click here to view full article